SCIOS INC
10-Q, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: SCIOS INC, 10-Q, 2000-08-14
Next: PRESIDENTIAL ASSOCIATES I LTD PARTNERSHIP, 10QSB, 2000-08-14



<TABLE> <S> <C>


<ARTICLE>       5
<LEGEND>

This  schedule  contains  summary  financial   information  extracted  from  the
consolidated   balance  Sheet,   consolidated   statement  of  operations,   and
consolidated statement of cash flows included In the Company's Form 10-Q for the
period  ending June 30,  2000,  and is qualified in its entirety By reference to
such financial statements.

</LEGEND>

<MULTIPLIER>                                            1,000

<S>                                                      <C>
<PERIOD-TYPE>                                                    6-MOS
<FISCAL-YEAR-END>                                          Dec-31-2000
<PERIOD-START>                                              Jan-1-2000
<PERIOD-END>                                               Jun-30-2000
<CASH>                                                          12,632
<SECURITIES>                                                    70,248
<RECEIVABLES>                                                    3,087
<ALLOWANCES>                                                         0
<INVENTORY>                                                          0
<CURRENT-ASSETS>                                                37,409
<PP&E>                                                          21,173
<DEPRECIATION>                                                  10,905
<TOTAL-ASSETS>                                                  97,910
<CURRENT-LIABILITIES>                                           29,106
<BONDS>                                                         44,876
<COMMON>                                                            38
                                                0
                                                          0
<OTHER-SE>                                                      23,890
<TOTAL-LIABILITY-AND-EQUITY>                                  97,910
<SALES>                                                         13,202
<TOTAL-REVENUES>                                                20,652
<CGS>                                                            7,703
<TOTAL-COSTS>                                                   40,178
<OTHER-EXPENSES>                                                   308
<LOSS-PROVISION>                                                    0
<INTEREST-EXPENSE>                                               2,010
<INCOME-PRETAX>                                               (19,834)
<INCOME-TAX>                                                         0
<INCOME-CONTINUING>                                           (19,834)
<DISCONTINUED>                                                       0
<EXTRAORDINARY>                                                      0
<CHANGES>                                                            0
<NET-INCOME>                                                  (19,834)
<EPS-BASIC>                                                     (0.52)
<EPS-DILUTED>                                                   (0.52)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission